Jagsonpal
Pharmaceuticals
Shareholder's Information
Issue of Shares Only in Dematerialised Form
1. The Company shall henceforth issue shares in dematerialised form only while processing the following service
requests in terms of Circular no. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated 25th January, 2022:
(1) Issue of duplicate share certificate
(2) Claim from Unclaimed Suspense Account
(3) Renewal / exchange of share certificate
(4) Endorsement
(5) Sub-division / Splitting of share certificate
(6) Consolidation of share certificates / folios
(7) Transmission
(8) Transposition
The shareholders holding shares of the Company in physical form, while sending any of the aforesaid service requests to the Company or RTA, should submit the prescribed Form ISR-4, duly filled up and complete in all respects.
2. SEBI has, vide the Circular No. SEBI/HO/MIRSD/MIRSD-PoD-1/P/CIR/2023/37 dated March 16, 2023 revised the norms/
procedural requirements for processing service requests with regard to furnishing of PAN, Address with PIN, email
address, mobile number, bank account details and nomination by holders of physical securities.
Folios wherein any one of the cited document / details are not available on or after October 01, 2023, such folios shall
be frozen by the Registrars and Transfer Agent of the Company (RTA)”
Shareholder`s Communication
S.No | Form | Purpose | Download |
|---|---|---|---|
1 | Form ISR -1 | Request for registering PAN, KYC details or changes / update thereof | |
2 | Form ISR -2 | Confirmation of Signature of shareholder by the Bank | |
3 | Form ISR -3 | Declaration for Opting-out of Nomination by holders of physical shares | |
4 | Form ISR -5 | Request for Transmission of Securities by Nominee or Legal heir | |
5 | Form SH – 13 | Nomination Form | |
6 | Form SH – 14 | Cancellation or Variation of Nomination |
Tax Communication